Newly published study: Pascallerg in Allergic Rhinitis
A study focused on PASCALLERG® was recently published in the German medical journal Forschende Komplementärmedizin. This study examined patients who had had allergic rhinitis (inflammation of the nasal passages) for an average of 11 years. Treatment with PASCALLERG® tablets over just four weeks resulted in 91.5% of patients having mild or no symptoms. Quality of life was improved in 97% of patients. Click on the link to read the full study.